Results 151 to 160 of about 21,776,804 (321)

Model Misspecification [PDF]

, 2015
Moosa, I., Burns, Kelly
openaire   +2 more sources

Intranasal diamorphine population pharmacokinetics modeling and simulation in pediatric breakthrough pain

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 435-447, March 2025.
Abstract Intranasal diamorphine (IND), approved for managing breakthrough pain in the UK, has been identified as an acceptable alternative offering effective, expedient, and less traumatic analgesia for children. However, the current dose regimen in pediatric populations relies on clinical expertise while the pharmacokinetics properties are poorly ...
Lianjin Cai, Jingchen Zhai, Beihong Ji, Fengyang Han, Taoyu Niu, Luxuan Wang, Junmei Wang   +6 more
wiley   +1 more source

On testing for homogeneity with zero-inflated models through the lens of model misspecification. [PDF]

Int Stat Rev, 2022
Hsu WW, Mawella NR, Todem D.
europepmc   +1 more source

Errors in recorded security prices and the turn-of-the year effect [PDF]

A study that concludes recorded security price errors are potential sources of misspecification in joint tests of the capital asset pricing model and market efficiency.Stock ...
James B. Thomson
core  

Semi‐mechanistic population PK/PD model to aid clinical understanding of myelodysplastic syndromes following treatment with Venetoclax and Azacitidine

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 448-459, March 2025.
Abstract Myelodysplastic syndromes (MDS) represent a group of bone marrow disorders involving cytopenias, hypercellular bone marrow, and dysplastic hematopoietic progenitors. MDS remains a challenge to treat due to the complex interplay between disease‐induced and treatment‐related cytopenias.
Neha Thakre, Corinna Maier, Jiuhong Zha, Benjamin Engelhardt, Johannes E. Wolff, Sven Mensing   +5 more
wiley   +1 more source

Use of the Lagrange Multiplier Test for Assessing Measurement Invariance Under Model Misspecification. [PDF]

Educ Psychol Meas, 2022
Guastadisegni L, Cagnone S, Moustaki I, Vasdekis V.   +3 more
europepmc   +1 more source

Inflation persistence, structural breaks and omitted variables: a critical view [PDF]

Recent empirical contributions assess time changes in inflation persistence by means of simple autoregressive models. Their reliability is discussed in the light of the econometric literature on model misspecification and it is showed that their results ...
Andrea Vaona
core  

Mirikizumab pharmacokinetics and exposure–response in pediatric patients with moderate‐to‐severe ulcerative colitis

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 474-485, March 2025.
Abstract Mirikizumab is a p19‐directed anti‐interleukin‐23 antibody approved for the treatment of adults with moderate‐to‐severe ulcerative colitis (UC). Here, we report the first data of mirikizumab pharmacokinetics (PK) and exposure–response (E/R) relationships in pediatric participants (aged 2 to <18 years weighing >10 kg) with moderate‐to‐severe UC
Yuki Otani, Laiyi Chua, Wendy J. Komocsar, Amy Larkin, Jordan Johns, Xin Zhang   +5 more
wiley   +1 more source

Sensitivity of Fit Indices to Model Complexity and Misspecification in Exploratory Structural Equation Modeling

Psychology International
Exploratory structural equation modeling (ESEM) allows items to cross-load on nontarget factors and provides flexibility in modeling multidimensional survey data.
Xinya Liang, Chunhua Cao, Ji Li, Ejike J. Edeh, Jiaying Chen, Wen-Juo Lo   +5 more
doaj   +1 more source

Assessment of Glucose Lowering Medications' Effectiveness for Cardiovascular Clinical Risk Management of Real-World Patients with Type 2 Diabetes: Targeted Maximum Likelihood Estimation under Model Misspecification and Missing Outcomes. [PDF]

Int J Environ Res Public Health, 2022
Sciannameo V, Fadini GP, Bottigliengo D, Avogaro A, Baldi I, Gregori D, Berchialla P.   +6 more
europepmc   +1 more source